Healthcare provider profile · identity verified

Janice A Lindstrom, MD

Family Practice · EAGLE POINT, OR · NPI 1720184013

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	524	160
Lisinopril	Lisinopril	473	146
Levothyroxine Sodium	Levothyroxine Sodium	312	90
Amlodipine Besylate	Amlodipine Besylate	296	93
Losartan Potassium	Losartan Potassium	269	88
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	213	42
Gabapentin	Gabapentin	210	54
Metformin Hcl	Metformin Hcl	192	56
Simvastatin	Simvastatin	192	56
Pantoprazole Sodium	Pantoprazole Sodium	189	67
Metoprolol Succinate	Metoprolol Succinate	173	49
Atenolol	Atenolol	164	52
Potassium Chloride	Potassium Chloride	139	43
Albuterol Sulfate Hfa	Albuterol Sulfate	135	67
Trazodone Hcl	Trazodone Hcl	131	46
Alendronate Sodium	Alendronate Sodium	130	40
Metoprolol Tartrate	Metoprolol Tartrate	125	38
Montelukast Sodium	Montelukast Sodium	125	47
Furosemide	Furosemide	110	36
Hydrochlorothiazide	Hydrochlorothiazide	106	35
Tizanidine Hcl	Tizanidine Hcl	104	38
Meloxicam	Meloxicam	93	38
Omeprazole	Omeprazole	92	26
Rosuvastatin Calcium	Rosuvastatin Calcium	80	28
Tamsulosin Hcl	Tamsulosin Hcl	79	27
Pravastatin Sodium	Pravastatin Sodium	77	19
Glipizide	Glipizide	74	24
Fluoxetine Hcl	Fluoxetine Hcl	71	24
Pradaxa	Dabigatran Etexilate Mesylate	71	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	21
Sertraline Hcl	Sertraline Hcl	64	20
Warfarin Sodium	Warfarin Sodium	62	13
Prednisone	Prednisone	61	30
Alvesco	Ciclesonide	58	19
Metformin Hcl Er	Metformin Hcl	54	17
Triamcinolone Acetonide	Triamcinolone Acetonide	51	29
Lorazepam	Lorazepam	50	14
Bupropion Xl	Bupropion Hcl	49	15
Escitalopram Oxalate	Escitalopram Oxalate	49	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	48	45
Finasteride	Finasteride	46	14
Citalopram Hbr	Citalopram Hydrobromide	45	17
Mirtazapine	Mirtazapine	45	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Oxycodone Hcl	Oxycodone Hcl	44	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	15
Wixela Inhub	Fluticasone Propion/Salmeterol	41	15
Allopurinol	Allopurinol	39	13
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Spironolactone	Spironolactone	39	13
Carvedilol	Carvedilol	38	12
Humulin N	Insulin Nph Human Isophane	38	12
Clopidogrel	Clopidogrel Bisulfate	37	11
Pregabalin	Pregabalin	35	12
Terazosin Hcl	Terazosin Hcl	35	11
Ozempic	Semaglutide	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	11
Doxycycline Monohydrate	Doxycycline Monohydrate	33	27
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Ondansetron Odt	Ondansetron	31	19
Jardiance	Empagliflozin	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Estradiol	Estradiol	29	13
Yuvafem	Estradiol	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Ketoconazole	Ketoconazole	26	12
Baclofen	Baclofen	25	suppressed
Famotidine	Famotidine	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Nitroglycerin	Nitroglycerin	20	11
Trospium Chloride	Trospium Chloride	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Metronidazole	Metronidazole	19	11
Propranolol Hcl	Propranolol Hcl	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	15
Eszopiclone	Eszopiclone	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	17	suppressed
Digoxin	Digoxin	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Eliquis	Apixaban	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Risperidone	Risperidone	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	13	13
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nystatin	Nystatin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error